- Active
- Exited
We are invested in mPharma Data Inc through Novastar Ventures Africa Fund II, which is managed by Novastar Ventures Limited.
We do not hold direct relationships with the companies that investment funds invest in. Instead, we hold relationships directly with the fund. When investing through investment funds, CDC takes an active role as a limited partner to the fund, working with the fund manager to ensure best practices, including in environment, social and governance matters, and investment management oversight.
Key facts
- Status:
- Active
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Health
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- Fund:
- Novastar Ventures Africa Fund II
- Fund Manager:
- Novastar Ventures Limited
- Start date
:
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- May 2019
- Domicile
:
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- USA
Our investment
We invested in the business alongside Novastar Ventures, a CDC-backed venture capital fund manager, to support the company in adding more pharmacies to its network, and developing a more efficient supply chain for pharmaceutical products across Africa.
| Impact |
|---|
Improve healthcare outcomes by improving accessibility and affordability to safe and high-quality medicines (SDG 3.8). |
| How? |
|---|
|
Catalysing markets: Aggregating purchasing power across a highly fragmented market enabling efficiencies and bringing down costs. |
| Stakeholder | Geography | Characteristics |
|---|---|---|
| Patients |
Current key markets: Ghana, Nigeria, Kenya, Rwanda, Zambia and Ethiopia. |
The company has a clear intent and ambition to reach the low-income mass market. |
| Scale | Depth/Duration |
|---|---|
|
The company’s ambition is to reach millions of patients by providing affordable and high-quality medicines and health services. |
|
| Grid Score | Contribution |
|---|---|
|
This investment is made under an approved Catalyst Strategy, and therefore does not require a grid score. To help us direct our investments, we use a tool called the Development Impact Grid. The Grid scores every investment we plan out of a score of four, based on two factors: the difficulty of investing in the country and whether investment in that sector will lead to jobs. |
|
| Risk |
|---|
|
Environmental and social aspects
As a co-investment under our venture capital scale-up programme, we worked collaboratively with Novastar Ventures (our co-investment partner) to agree an environmental and social (E&S) action plan with mPharma. Key items focused on developing an E&S management system, occupational health and safety, waste management, and data privacy and security.
Key facts
- Status:
- Active
- Region
:
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa
- Sector
:
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Health
- Investment type
:
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Co-Investments Equity
- Start date
:
For direct investments, this is the date CDC committed capital to the business or project.
For funds, this is the date that CDC committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- March 2020
- Amount
:
For direct investments, this is the total amount that CDC has committed to the business or project (it may be a combination of equity and debt).
For funds, this is the total amount that CDC has committed to the fund.
- $2m
- Domicile
:
This is the investee company’s place of incorporation; or a fund’s jurisdiction.
- USA
